The latest financial statement is for the quarter ending 2025-12-31.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net income | 501,396 | 444,293 | 42,445 |
| Depreciation and amortization | 70,976 | 69,994 | 295,003 |
| Recovery of credit losses | 33,000 | -40,000 | -93,833 |
| Stock based compensation expense | 38,600 | 38,868 | 156,682 |
| Esop expense | 35,439 | 35,438 | 61,667 |
| Provision for valuation allowance on foreclosed assets (oreo), net | - | - | 378,767 |
| Net amortization of discounts and premiums on debt securities | -890 | -1,154 | -45,702 |
| Amortization of deferred loan fees, net | 19,291 | 33,335 | 51,859 |
| Net gain on sale of loans | 28,983 | 41,161 | 148,203 |
| Deferred tax expense (benefit) | -62,464 | 28,595 | -12,761 |
| Earnings on cash value of life insurance | 71,550 | 69,893 | 269,888 |
| (increase) decrease in interest receivable | 5,384 | 32,956 | 69,918 |
| Originations of loans held for sale | 518,000 | 1,632,024 | 5,907,284 |
| Proceeds from loans held for sale | 546,983 | 1,673,185 | 6,055,487 |
| Net change in operating leases | 58 | 57 | 1,209 |
| Net change in other assets | -106,109 | 107,801 | -27,067 |
| Net change in other liabilities | 785,577 | 129,547 | 938,228 |
| Net cash provided by operating activities | 1,413,356 | 463,961 | 1,448,511 |
| Net change in interest-bearing deposits in other financial institutions | -641,952 | 581,031 | 37,359 |
| Proceeds from maturities, calls and repayments of debt securities available for sale | 1,150,284 | 93,654 | 1,703,945 |
| Proceeds from maturities and calls of debt securities held to maturity | 7,241 | 14,379 | 32,768 |
| Net (increase) decrease in loans | 5,667,675 | 5,389,646 | 17,202,381 |
| Purchases of property and equipment | 14,019 | 7,327 | 179,043 |
| Cash received from mhc in conversion | - | - | 100,000 |
| Net cash (used in) provided by investing activities | -3,882,217 | -5,869,971 | -15,582,070 |
| Net cash proceeds from common stock offering | - | - | 15,210,356 |
| Exercise of stock options | - | - | 13,314 |
| Purchase of esop shares | - | - | 1,354,720 |
| Net change in deposits | -3,334,137 | 6,480,764 | 2,260,072 |
| Proceeds from fhlb advances, net | 4,000,000 | - | 5,000,000 |
| Repayments of fhlb advances | - | - | 3,000,000 |
| Purchase and retirement of common stock | - | - | 82,165 |
| Net cash provided by (used in) financing activities | 665,863 | 6,480,764 | 18,046,857 |
| Net change in cash and cash equivalents | -1,802,998 | 1,074,754 | 3,913,298 |
| Cash and cash equivalents at beginning of period | 15,460,490 | 14,385,736 | 10,472,438 |
| Cash and cash equivalents at end of period | 13,657,492 | 15,460,490 | 14,385,736 |
Marathon Bancorp, Inc. MD (MBBC)
Marathon Bancorp, Inc. MD (MBBC)